In vivo gene editing for inherited vision loss

RESEARCH HIGHLIGHT 20 May 2024

An early-phase trial suggests safety and improvements in vision after treatment with the CRISPR-based therapy EDIT-101, providing proof of concept for in vivo retinal gene editing.